baber/WOPTO huggingface dataset:
Patent NZ-214029-A (NZ)
Title: Egg yolk slurry acidified and sterilised
Inventor: WENGER U
IPC: A23B5/08
Filed: 1985-10-31
Abstract: 57 A process for sterilising egg yolk characterised in that an aqueous slurry of egg yolk is acidified to a pH of less than 6.0 and then sterilised under ultra high temperature processing conditions as well as a process for preparing sterilised food products containing egg yolk.
Patent NZ-215721-A (NZ)
Title: An amine-epoxide reaction product for electrodeposition as a coating compound
Inventor: BERESFORD M P
IPC: C08G59/56
Filed: 1986-04-07
Abstract: Non-gelled amine-epoxide reaction products are obtained by co-reacting a secondary amine, a polyoxyalkylene polyamine, a polyepoxide and optionally a monoepoxide. The products are crosslinkable and are useful in aqueous coating compositions, particularly when applied to a substrate by cathodic electrodeposition.
Patent NZ-217079-A (NZ)
Title: Peptide derivatives and pharmaceutical compositions
Inventor: VINCENT M
IPC: A61P25/28
Filed: 1986-08-04
Abstract: New peptide compounds having a lactone or cycloamide structure and containing a saturated bicyclic structure, pharmaceutically-acceptable acid addition salts thereof, method for the preparation thereof, pharmaceutical compositions containing the same, and use thereof for the stimulation of cyclic AMP in the cerebral tissue and consequently increasing the metabolic capacities of the brain, thereby making them of interest in the treatment of diseases of the central nervous system or disorders approximating normal or pathological aging, are disclosed.
Patent NZ-227840-A (NZ)
Title: Device for decreasing the leukocyte content of a platelet concentrate comprising a porous fibrous medium
Inventor: PALL DAVID BORIS
IPC: A61M1/36
Filed: 1989-02-02
Abstract: A device for the depletion of the leukocyte content in a platelet concentrate, preferably comprising a modified porous, fibrous medium with a critical wetting surface tension of at least about 90 dynes/cm and a method for the depletion of the leukocyte content and platelet concentrate comprising passing the platelet concentrate through the porous medium.
Patent NZ-230984-A (NZ)
Title: Vehicle anti-theft system: keyboard code entry enables engine starting
Inventor: GARRETTO MICHAEL ANTHONY
IPC: B60R25/04
Filed: 1988-02-10
Abstract: PCT No. PCT/AU88/00030 Sec. 371 Date Aug. 17, 1989 Sec. 102(e) Date Aug. 17, 1989 PCT Filed Feb. 3, 1988 PCT Pub. No. WO88/06110 PCT Pub. Date Aug. 25, 1988.An anti-theft vehicle system comprises a relay (R1) which shuts off power to an engine coil (14), fuel pump (16) or fuel flow valve (50) to prevent the engine from starting until the reset device in the form of a switch (S1) or a keyboard (150) is activated. Relay (R1) is controlled by a processor (100) which is coupled to a keyboard (150) so that when a code is keyed into the keyboard (150) the processor outputs a signal to the relay to cause the relay to supply power to the engine coil (14), fuel pump (16) or flow valve (50).
Patent NZ-231060-A (NZ)
Title: Nitroxyalkylamines and pharmaceutical compositions thereof
Inventor: SIMON HERBERT
IPC: C07D295/185
Filed: 1989-10-18
Abstract: The present invention provides pharmaceutical compositions effective against angina-like heart and circulatory diseases containing at least one nitroxyalkylamine derivative of the general formula: <IMAGE> (I)  wherein R1 is a hydrogen atom, a lower-alkyl radical, a C3-C8-cycloalkyl or C3-C8-cycloalkenyl radical, an aminocarbonyl, C1-C6-mono- or di-alkylaminocarbonyl radical, R2 is a hydrogen atom, a lower-alkyl radical or a C3-C8-cycloalkyl or cycloalkenyl radical or R2, together with R1 and the nitrogen atom to which they are attached, form a heteroaliphatic ring containing up to 6 carbon atoms, A is a valency bond or a straight-chained or branched lower-alkylene radical, in which a -CH2- group can be replaced by a cycloalkylene radical, B is a lower-alkylene radical, in which a -CH2- group can be replaced by a cycloalkylene radical and X is an -NR3-CO- or -CO-NR3- radical, in which R3 is a hydrogen atom or a lower-alkyl radical, when X is an -NR3-CO- radical, R3, together with the nitrogen atom and a carbon atom of the group A, bridge a heterocyclic ring containing 4 to 6 carbon atoms or R3, together with R2, A and the two nitrogen atoms, bridge a heterocyclic ring containing 3 to 5 carbon atoms; and the optically-active forms and physiologically acceptable salts thereof.
Patent NZ-235297-A (NZ)
Title: Aqueous solution containing a protein and anionic polymer or salt and method of increasing the protein concentration of an aqueous solution
Inventor: YUKIO SHIMAZAKI
IPC: A61K47/42
Filed: 1990-09-13
Abstract: Aqueous protein-containing solutions, in which a protein is dissolved at a high concentration at a pH near the isoelectric point of the protein by adding an anionic polymer or a salt thereof to the solution. Pharmaceutical formulations using a physiologically active protein are prepared using this technique.
Patent NZ-236141-A (NZ)
Title: Using low molar aqueous concentration of urea in solubilisation/naturation and isolation/purification of somatotropins
Inventor: MCCOY KEVIN MICHAEL
IPC: C07K1/00
Filed: 1990-11-20
Abstract: The present invention relates to a process for solubilization and naturation of somatotropins utilizing a combination of low urea solution and an aqueous alkaline solution. By utilizing the process of the present invention, enhanced yields of end product result.
Patent NZ-258442-A (NZ)
Title: Preparation of tablets containing various bisphosphonic acid derivatives
Inventor: BECHARD SIMON R
IPC: A61K9/20
Filed: 1993-11-17
Abstract: Prepn. of a tablet contg. a bisphosphonic acid deriv. (BP), comprises (a) forming a mixt. contg. the BP, anhydrous or fast flow lactose, dry binder and disintegrant; (b) opt. adding compression aids, flavours, flavour enhancers, sweeteners, and preservatives; (c) lubricating with a lubricant; and (d) compressing to the desired tablet form. The (BP) are chosen from 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid; and its N-methyl and N,N-dimethyl analogues, 3-amino-1-hydroxypropylidene-1,1-bisphosphonic acid and its N,N-dimethyl and N-methyl-N-pentyl analogues; 1-hydroxy-2-(3-pyridyl)ethylidene-1,1-bisphosphonic acid and 4-hydroxymethylene-1,1-bisphosphonic acid piperidine; or their salts. More pref. is 4-amino-1-hydroxybutylidene -1,1-bisphosphonic acid (BP-1) partic. as monosodium salt trihydrate (BP-2). The dry binder is microcrystalline cellulose (MC). The disintegrant is modified starch or cellulose polymer, croscarmellose sodium (CC-Na) or a mixt. esp. CC. The lubricant is Mg stearate. Compsn. range is basic BP 0.5-25, lactose 30-70, MC 30-50, CC-Na 0.5-5 and mg stearate 0.1-2, all %. Closer limits, for BP-2 are BP-2 1-25, lactose 40-60, MC 35-45, CC-Na 0.5-2, and Mg stearate 0.1-1 all %.
Patent NZ-263455-A (NZ)
Title: Synthesis of platelet glycoprotein iib/iiia inhibitors
Inventor: ZHANG LIN-HUA
IPC: C07K7/56
Filed: 1994-03-28
Abstract: This invention provides processes for the synthesis of platelet glycoprotein IIb/IIIa inhibitors and intermediate compounds useful in said processes. The compounds afforded by this invention have the formula:    <IMAGE>  Formula (I)
Patent NZ-320914-A (NZ)
Title: Methods and compositions for controlling biofouling using oxime esters
Inventor: ZOLLINGER MARK L
IPC: A01N37/16
Filed: 1996-09-27
Abstract: Disclosed is a method to inhibit bacteria from adhering to a submergible surface. The method contacts the submergible surface with an effective amount of at least one oxime ester to inhibit bacterial adhesion to the submergible surface. A method for controlling biofouling of an aqueous system is also disclosed. This method adds an effective amount of at least one oxime ester to inhibit bacteria from adhering to a submerged surface within the aqueous system. This method effectively controls biofouling without substantially killing the bacteria. The oxime ester used in the method of the invention has formula (I). Disclosed are compositions containing oxime esters and useable in the above methods. The compositions comprise at least one oxime ester in an amount effective to inhibit bacteria from adhering to submergible or submerged surfaces.
Patent NZ-328533-A (NZ)
Title: Snoring inhibitor, leg ends of w-shaped frame insert into nostrils
Inventor: SUGERMAN JOSEPH HARRY
IPC: A61F2/82
Filed: 1997-08-11
Abstract: A device for enabling a person to breathe more easily while alleviating snoring problems. The device (10) is a generally W-shaped frame (20) providing a pair of suitably sized spacing tips (12) for insertion into the user's nostrils. These tips serve to open and shape the nasal passages so that breathing is facilitated. <IMAGE>
Patent NZ-335485-A (NZ)
Title: Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
Inventor: CHEN YAO-TSENG
IPC: C07K14/47
Filed: 1997-09-15
Abstract: An isolated nucleic acid molecule which encodes the cancer associated antigen depicted in figure 3.  The antigen, and the use of the antigen and the nucleic acid and peptides derived from it.
Patent NZ-335907-A (NZ)
Title: Pressure sensitive adhesives with low level of residual monomers and process for manufacturing same
Inventor: HILLE THOMAS
IPC: C09J133/00
Filed: 1997-10-14
Abstract: A pressure-sensitive adhesive that comprises one or more polymers prepared from olefinic monomers.  After completion of polymerisation, or copolymerisation, of the polymer(s), the adhesive is hydrogenated in an organic solvent in the presence of a heterogeneous or homogenous catalyst.  This reaction is carried out at a temperature of up to 150oC and at a hydrogen pressure of up to 100 bar.  This process forms a pressure-sensitive adhesive with a content of free monomers of less than 0.3% by weight.  Also disclosed is a transdermal therapeutic system, a medicinal, veterinary, cosmetic or food sector composition that comprises the above adhesive.
Patent NZ-500391-A (NZ)
Title: An improved spraying device having a spraying head and a ball valve in a conduit
Inventor: STYNE JAMES J
IPC: B05B7/12
Filed: 1998-02-16
Abstract: A spraying device for mixing a first fluid with a second fluid prior to dispensing into the environment. The spraying device includes a spraying head connected to a cartridge bottle. A shroud covers the spraying head to cartridge bottle connection. The chemical remains in a closed system even after the cartridge bottle is attached to the spraying head. A unique gear and/or cam system is provided to open the flow path of the second fluid and provide a positive operation. Also, the orifice diameter of the second fluid flow path is predetermined.
Patent NZ-501489-A (NZ)
Title: Adhesive bandage for fingers or toes having three distinct wrapping sections
Inventor: MURPHY PAUL A
IPC: A61F13/10
Filed: 1999-12-02
Abstract: Described is a bandage which firmly envelops an affected part on a fingertip or toe to exclude the invasion of water, bacteria and the like. The bandage comprises a first adhesive portion which is adhered to a finger cushion surface, and a second adhesive portion which is folded from the finger cushion side to be adhered to the nail-side surface of the fingertip so as to face the first adhesive portion across the fingertip. The first adhesive portion has projecting portions which are folded from the finger cushion side and adhered to each side surface of the fingertip. The second adhesive also portion has projecting portions folded from the nail side toward the finger cushion side that wind around the fingertip.
Patent NZ-501790-A (NZ)
Title: Rose-hip formulations as anti-inflammatory for arthritis
Inventor: REIN EYDBJORG
IPC: A23L33/15
Filed: 1999-04-16
Abstract: A method for producing a formulation containing a rose-hip concentrate having a high vitamin content comprising obtaining a plurality of rose-hips; fracturing the rose-hips into pieces, separating a flesh portion of the rose-hips from other matter, drying the flesh portion of the rose-hips at temperatures below 50oC, to a water content of 5%, grinding the dried flesh portion of the rose-hips to produce a powder; and providing the powder in a physiologically acceptable form. The formulation is used for the treatment of symptoms associated with inflammation, including arthritis.
Patent NZ-502191-A (NZ)
Title: E-mail system, which allocates addresses containing owner's name and telephone number
Inventor: MEIER ALAN JAMES
IPC: H04L12/58
Filed: 2000-01-05
Abstract: E-mail addresses are produced using the owner's name and telephone number.  Typically the address will be made up of the owner's name and all or part of the telephone number.  It is intended that the e-mail addresses be allocated en masse by an ISP to a large group of people, such as those listed in a telephone directory.  The e-mail addresses will be used to form a database.  The database will be available to senders of e-mail.  If a message is sent to one of the allocated e-mail addresses, the ISP will check to see if the addressee is registered with the ISP.  If the addressee is not registered, then the addressee will be contacted and invited to register with the ISP in order to receive the message.
Patent NZ-503268-A (NZ)
Title: Apparatus and method for applying deformable metal fastener clips to concrete reinforcement steel
Inventor: NOWELL STEPHEN
IPC: E04G21/12
Filed: 1998-09-09
Abstract: A hand held applicator tool (110) and method for applying deformable metal fastener clips (20) to secure together reinforcement steel members (50,51) used in concrete construction. The deformable metal fastener clips are generally U-shaped members that are open on one side before being deformed so that the fastener clips can be easily placed over the reinforcement steel members. The tool comprises a frame (70), an anvil (111) supported at one end of the frame, a movable blade assembly (63) supported for sliding movement along the frame toward the anvil, and a handle for manipulating and positioning the tool. The movable blade assembly has a generally U-shaped receptacle for holding a fastener clip. The anvil has a pair of machined grooves for guiding the first and second legs of a fastener clip generally toward one another to close the open side of the fastener clip and deform the first and second legs to clamp tightly around the reinforcement members.
Patent NZ-504352-A (NZ)
Title: Meter for determining concentrations of components (eg; glucose) in biological fluid samples (eg; blood)
Inventor: BEATY TERRY ALLEN
IPC: G01N27/02
Filed: 1998-12-21
Abstract: An apparatus (31) for determining the concentration  of a  medically  significant component of a  biological  fluid, the  apparatus comprising a cell (31) for receiving a sample of  the  fluid, the cell supporting a chemistry which reacts with  the  medically  significant component  and  first  and second  terminals across which the reaction of the chemistry with  the  medically significant component can be  assessed, an  instrument  (32) having first (34-2) and  second  (34-3) terminals  complementary to the first and second  terminals, respectively,  of  the  cell, placement  of  the  first  and second  terminals of the cell in contact with the first  and second    terminals,   respectively,   of   the   instrument permitting  the  instrument  to  assess  the  reaction,  the instrument  including  an  assessment  controller  (52,  54) configured  to  apply across the first and second  terminals of  the instrument a first signal having an AC component, to determine a first correction value in response of  the  cell to  first  signal, to assess the reaction of  the  medically significant component with the chemistry and to combine  the correction  value with the result of the reaction assessment to  produce  an  indication  of  the  concentration  of  the medically significant component in the sample.
Patent NZ-505208-A (NZ)
Title: Use of macrolides in pest control
Inventor: HALL ROGER GRAHAM
IPC: A01N43/00
Filed: 1998-12-21
Abstract: Method of controlling pests in crops of transgenic plants using a pesticide composition. The composition comprises an active ingredient(s) of at least one compound selected from Abamectin, Emaectin and Spinosad in free form or in agrochemically useful salt form. Also at least one auxiliary is applied to the pest or their environment. The transgenic plant contains one or more genes expressing an insecticidally, acaricidally, nematocidally or fungicidally active ingredient. The useful transgenic crop is selected from maize, tomatoes, wheat, barley, potatoes, oil seed rape, brassicae and sunflower.
Patent NZ-506972-A (NZ)
Title: Oxygen scavengers with reduced oxidation products for use in plastic films and beverage and food containers
Inventor: CHING TA YEN
IPC: C08F22/04
Filed: 1999-03-24
Abstract: A  composition  for scavenging  oxygen,  comprising  a mixture of: (A)   a  polymer  or  oligomer  containing  the  cyclohexene functionality  of  formula (I), wherein  A  is  hydrogen  or methyl  and  either  one or two B groups  is  a  heteroatom- containing  linking group with the polymer or oligomer,  and the remaining B groups are hydrogen or methyl, and (B) a transition metal catalyst.
Patent NZ-507148-A (NZ)
Title: Vending machine
Inventor: HUFFMAN JOHN P
IPC: G07F9/10
Filed: 2000-09-26
Abstract: A vending machine, comprising: a monetary unit; a housing having a floor and forming an interior space with open front; a door attached to the housing for pivotal movement between an open position for allowing access to the interior space of the housing through the open front and a closed position for covering the open front; a horizontal shelf in the housing dividing the interior space of the housing into upper and lower portions, the shelf defining an opening along an edge thereof extending towards the open front of the housing; a refrigeration unit having substantially vertical side portions engageable with the edge of the shelf defining the opening therein, the refrigeration unit being slidable on the floor of the housing into the housing with the frontdoor in the open position such that the vertical side portions engage the edge of the shelf along substantially the length of the opening therein; a temperature sensing probe; and a controller associated with the refrigeration unit and the temperature sensing probe.
Patent NZ-511426-A (NZ)
Title: Biological materials and methods useful in the diagnosis and treatment of diseases
Inventor: COLLINGE JOHN
IPC: C12P21/08
Filed: 1999-11-02
Abstract: A method of making a monomeric beta-form of a prion protein which has more beta-sheet than alpha-helix structure and is soluble in the absence of a denaturant and wherein the beta-form is the dominant prion protein species; the use of a monomeric beta-form preparation in the manufacture of a composition for use in the prevention, treatment and/or diagnosis of a prion disease; A method of making antibodies against the beta-form of a prion protein or an aggregate thereof; a method of making of making a non-fibrillar prion protein aggregate; a method for detecting the aggregate in a biological sample; and a method of identifying an agent which is capable of preventing, reducing and/or reversing the conversion of a prion protein to a beta-form.
Patent NZ-512056-A (NZ)
Title: HBV core antigen particles with multiple immunogenic components attached via peptide ligands
Inventor: MURRAY KENNETH
IPC: C07K19/00
Filed: 1999-12-03
Abstract: Disclosed are hepatitis B virus ("HBV") core antigen particles that are characterized by multiple immunogen specificities. More particularly disclosed are HBV core antigen particles comprising immunogens, epitopes, or other related structures, crosslinked thereto by ligands that are HBV capsid-binding peptides that selectively bind to HBV core protein. Such particles may be used as delivery systems for a diverse range of immunogenic epitopes, including the HBV capsid-binding peptides, which advantageously also inhibit and interfere with HBV viral assembly by blocking the interaction between HBV core protein and HBV surface proteins. Mixtures of different immunogens and/or capsid-binding peptide ligands may be crosslinked to the same HBV core particle. Such resulting multicomponent or multivalent HBV core particles may be advantageously used in therapeutic and prophylactic vaccines and compositions, as well as in diagnostic compositions and methods using them.
Patent NZ-512535-A (NZ)
Title: Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
Inventor: KELLER BRADLEY T
IPC: A61K31/56
Filed: 1999-12-17
Abstract: The present invention provides combinations of cardiovascular therapeutic compounds for the prophylaxis or treatment of cardiovascular disease including hypercholesterolemia, atherosclerosis, or hyperlipidemia. Combinations disclosed include an ileal bile acid transport inhibitor combined with a bile acid sequestrant.
Patent NZ-515330-A (NZ)
Title: Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
Inventor: HASSE DETLEF
IPC: A61K48/00
Filed: 2000-05-11
Abstract: Therapeutic compositions for the treatment and/or prophylaxis of intestinal disease conditions in animals and birds caused or exacerbated by Lawsonia intracellularis or similar or otherwise related microorganism, in particular a gene derived from Lawsonia intracellularis which encodes an immunogenic OmpH peptide, polypeptide or protein that is particularly useful as an antigen in vaccine preparation for conferring humoral immunity against Lawsonia intracellularis and related pathogens in animal hosts, and methods for the treatment and/or prophylaxis of such intestinal disease conditions and to diagnostic agents and procedures for detecting Lawsonia intracellularis or similar or otherwise related microorganisms are disclosed.
Patent NZ-517422-A (NZ)
Title: Heterocyclic compounds inhibiting angiogenesis
Inventor: MAKK NANDOR
IPC: A61P35/00
Filed: 2000-08-02
Abstract: Borrelidin derivatives of general formula (I), wherein, R stands for a group of the general formula -COOR1, -CONR2R3 or -CONR4CONR4R5 , wherein R1 stands for a C1-6 alkyl group substituted by hydroxyl, amino, di(C1-4 alkyl)-amino group or 5-8 membered saturated, nitrogen-containing heterocyclic group or by 5- or 6- membered, nitrogen-containing aromatic heterocyclic group; or a C3-6 cycloalkyl group; R2 and R3 are identical or different and stand independently from each other for hydrogen atom or a C1-6 alkyl group which optionally may be substituted by halogen atom, hydroxyl, amino, C2-5 alkoxycarbonyl, di(C1-4 alkyl)-amino group or 5-8 membered saturated, nitrogen containing heterocyclic group or 5- or 6- membered aromatic homocyclic group or aromatic heterocyclic group containing an oxygen and/or nitrogen atom; a 5- or 6-membered cycloalkyl or a heteroaryl group; R4 and R5 are identical or different and stand independently from each other for a hydrogen atom, a C1-6 alkyl group, a C3-6 cycloalkyl group or a phenyl group, and their tautomers, solvates and the mixtures thereof and acid addition salts of these compounds are disclosed. Pharmaceutical compositions comprising compounds of general formula (I) as an angiogenesis-inhibiting active agent are also disclosed. These angiogenesis-inhibitors inhibit the neovascularisation in living tissues and as such can be used for preventing and inhibiting angiogenesis appearing in connection with tumour growth and for preventing the formation of tumour metastases. The pharmaceutical compositions disclosed can also be used in cancer therapy, treating arthritis or pannus and treating psoriasis.
Patent NZ-518149-A (NZ)
Title: Herbicidal glyphosphate composition and adjuvant which can include a phosphate ester
Inventor: KOENIG SHANE JOHN
IPC: A01N25/02
Filed: 2000-04-04
Abstract: Detailed is a herbicidal glyphosphate composition comprising the monoisopropylamine salt of glyphosate and the ammonium salt of glyphosphate. Also covered is a herbicidal composition in a dilute form for application to crops, comprising an aqueous solution of at least 3.6g/L of glyphosphate and a method for producing said glyphosphate compositions.